Location: Crowne Plaza Shanghai Noah Square Hotel – Grand Ballroom
Date:
Booth number: A3
Event description: The global field of central nervous system (CNS) drug development is evolving rapidly in response to growing patient needs and emerging scientific insights. As the incidence of neurodegenerative and psychiatric disorders increases, the need for effective, targeted therapies is more urgent than ever. ICNS 2025 will convene over 60 leaders across research, clinical development, and commercialization to explore the latest advancements and collaborative strategies driving innovation in CNS therapies. Novotech’s China Business Development team will be on-site at Booth A3 to meet with biotech and pharmaceutical sponsors aiming to accelerate CNS clinical development. With extensive experience in CNS trials across Asia-Pacific, Novotech offers full-service support, including complex trial design, integrated regulatory strategy, and operational execution tailored to high-risk therapeutic areas. Our regional expertise and proven capabilities help sponsors navigate complexity and achieve their development milestones efficiently across the region and beyond. Stop by Booth A3 to meet the Novotech team and learn how we can support your next CNS milestone.